SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
SCOR Se (SCRYY) trades at a trailing P/E of 84.6, forward P/E of 9.1. Trailing earnings yield is 1.18%, forward earnings yield 11.01%. PEG 0.01 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (15/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 84.6).
- Forward P/E 9.1 (down from trailing 84.6) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.01 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 1.18% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 11.01% as earnings recover.
Overall SharesGrow Score: 61/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
15/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
75/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SCRYY
Valuation Multiples
P/E (TTM)84.6
Forward P/E9.1
PEG Ratio0.01
Forward PEG0.01
P/B Ratio0.00
P/S Ratio4.47
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.05
Forward EPS (Est.)$0.43
Book Value / Share$0.00
Revenue / Share$0.87
FCF / Share$0.00
Yields & Fair Value
Earnings Yield1.18%
Forward Earnings Yield11.01%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.32 |
$14.37B |
$603M |
4.2% |
| 2017 |
$0.15 |
$15.33B |
$286M |
1.9% |
| 2018 |
$0.17 |
$15.64B |
$322M |
2.1% |
| 2019 |
$0.23 |
$15.03B |
$422M |
2.8% |
| 2020 |
$0.13 |
$15.42B |
$234M |
1.5% |
| 2021 |
$0.25 |
$16.03B |
$456M |
2.8% |
| 2022 |
$-0.17 |
$3.33B |
$-302M |
-9.1% |
| 2023 |
$0.45 |
$16.27B |
$812M |
5% |
| 2024 |
$0.00 |
$1.57B |
$4M |
0.3% |
| 2025 |
$0.05 |
$15.57B |
$817.41M |
5.2% |
